Amedica Corp (AMDA) 0.56 $AMDA
Amedica Announces Preliminary Q2 2015 Financial Results and Update on Recent FDA Response
GlobeNewswire - Mon Jul 27, 3:15PM CDT
Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopedic implants, today announced that it expects to report second quarter 2015 revenue in the range of $4.7 million and $4.9 million, as compared to $4.7 million during the first quarter of 2015.
AMDA: 0.56 (+0.01)
Amedica to enter into OEM supply agreement for silicon nitride spinal implants
M2 - Fri Jul 24, 6:07AM CDT
Biomaterial company Amedica Corporation (NasdaqCM:AMDA) reported on Thursday that it has signed an original equipment manufacturer (OEM) letter of intent supply agreement with a leading orthopedic device design and manufacturing company (customer) to provide superior and innovative solutions to the market.
AMDA: 0.56 (+0.01)
Amedica Corporation Signs Additional OEM Letter of Intent Supply Agreement
GlobeNewswire - Thu Jul 23, 3:15PM CDT
Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopedic implants, is pleased to announce that it has signed an original equipment manufacturer (OEM) letter of intent supply agreement with a leading orthopedic device design and manufacturing company.
AMDA: 0.56 (+0.01)
Early Briefing on Medical Appliances and Equipment Stocks - Amedica, Hologic, St. Jude Medical, AcelRx Pharma, and NuVasive
PR Newswire - Wed Jul 22, 8:00AM CDT
Equity Research Institute has initiated coverage on the following equities: Amedica Corporation (NASDAQ: AMDA), Hologic Inc. (NASDAQ: HOLX), St. Jude Medical Inc. (NYSE: STJ), AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX), and NuVasive Inc. (NASDAQ: NUVA). Free research report on Amedica can be accessed at https://www.EquityResearchInstitute.com/reports?keyword=AMDA On Tuesday, July 21, 2015, the NASDAQ Composite ended at 5,208.12, down 0.21%, the Dow Jones Industrial Average declined 1.00%, to finish the day at 17,919.29, and the S&P 500 closed at 2,119.21, down 0.43%. The losses were broad based as seven out of nine sectors ended the session in negative. Register for your complimentary reports at the links given below.
ACRX: 4.02 (+0.02), STJ: 74.06 (-0.13), NUVA: 54.52 (+4.05), HOLX: 37.71 (+0.17), AMDA: 0.56 (+0.01)
Amedica Corporation Provides Update on FDA Questions and Femoral Head Testing Protocol Feedback
GlobeNewswire - Tue Jul 07, 3:45PM CDT
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced that responses to the U.S. Food and Drug Administration ("FDA"
inquiries regarding the Company's cervical composite silicon nitride interbody device were submitted to the FDA on June 30, 2015. Additionally, the Company has received feedback from the FDA regarding its wear testing femoral head protocols.
AMDA: 0.56 (+0.01)
Spinal Fusion - Pipeline Review, 2015
M2 - Fri Jun 26, 3:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/26cwc3/spinal_fusion) has announced the addition of the "Spinal Fusion - Pipeline Review, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key spinal fusion pipeline products. Scope - Extensive coverage of the Spinal Fusion products under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Spinal Fusion and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Products under Development 4 Spinal Fusion - Pipeline Products under Development by Companies 5 Spinal Fusion Companies and Product Overview 6 Spinal Fusion - Recent Developments 7 Appendix Companies Featured: - 4-Web Spine, LLC - Alphatec Holdings, Inc. - Amedica Corporation - APTO Orthopaedics - Aurora Spine Corporation - Bio2 Technologies, Inc. - Bonovo Orthopedics, Inc. - Cortical Concepts (Inactive) - DiFusion Technologies Inc. - ECA Medical Instruments, Inc. - Eden Spine, LLC - Eminent Spine, LLC - Exactech, Inc. - Expanding Orthopedics Inc. - Globus Medical, Inc. - H. Lee Moffitt Cancer Center & Research Institute, Inc. - Implants International Limited - Integra LifeSciences Holdings Corporation - Intelligent Implant Systems, LLC - Intrinsic Therapeutics, Inc. - Jemo Spine, LLC. - Kspine, Inc. - Medtronic plc - MicroPort Scientific Corporation - Nasseo, Inc. - NLT SPINE - NuVasive, Inc. - OsteoGeneX Inc. - OsteoVantage, Inc. - Paradigm Spine, LLC For more information visit http://www.researchandmarkets.com/research/26...nal_fusion
ATEC: 1.37 (+0.01), MDT: 77.18 (-0.29), IARTV: 65.00 (-37.45), GMED: 27.40 (+0.11), EXAC: 20.01 (-0.07), NUVA: 54.52 (+4.05), AMDA: 0.56 (+0.01)
Asia Pacific Spine Surgery Devices Market 2015-2019: Non-Fusion Implants, Spinal Fusion & Fixation Devices, Spine Biologics, Spine Bone Stimulators, Vertebral Compression Fracture Treatment Devices
M2 - Thu Jun 25, 9:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w34wfd/asia_pacific) has announced the addition of the "Asia Pacific Spine Surgery Devices Market by Products (Non-Fusion Implants, Spinal Fusion & Fixation Devices, Spine Biologics, Spine Bone Stimulators, Vertebral Compression Fracture Treatment Devices), by End-User, by Geography - Analysis & Forecast" report to their offering. The APAC Spine Surgery Devices Market is expected to reach $2,223.1 million by 2019, at a CAGR of 10.5% from 2014 to 2019 This is mainly due to the increasing incidents of spinal deformities, such as disc compression amongst the aging population in the Asia-Pacific region, and the popularity of non-fusion devices, such as artificial spinal disc and nucleus. The increasing demand from the aging population, along with the advancement in medical technology, is driving the demand for the spine surgery device market in this region. In this report, the spine surgery devices market is broadly segmented into four classes such as fusion, non-fusion, spinal decompression, and spine biologics. The fusion category can be divided into spine fusion and fixation and spinal bone stimulators. Non-fusion segment consists of motion preservation technologies, such as dynamic stabilization, artificial discs, annual repair and nucleus replacement. The vertebral compression factures treatment category includes market for vertebroplasty and kyphoplasty kits. Spinal decompression segment consists of niche markets, such as corpectomy, disectomy, foraminotomy/forminectomy, and laminotomy/laminectomy. Allogarfts, bone morphonenetic proteins, demineralised bone matrix, bone substitutes, and machined bones together contribute to the overall category of spine biologics. New product launches, mergers & acquisitions, agreements, and approvals are the major strategies adopted by most of these market players to achieve growth in the APAC spine surgery devices market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Spine Surgery Devices Market, By Product 6 Spine Surgery Devices Market, By End-Users 7 Spine Surgery Devices Market, By Geography 8 Apac Spine Surgery Devices Market: Competitive Landscape 9 Spine Surgery Devices Market, By Company - Alphatec Spine, Inc. - Amedica Corporation - Biomet, Inc. - Depuy Synthes Companies. - Globus Medical, Inc. - Integra Lifesciences Holdings Corporation. - Medtronic, Inc. (U.S.) - Nuvasive Inc - Stryker Corporation - Zimmer Holding, Inc. For more information visit http://www.researchandmarkets.com/research/w3...ia_pacific
MDT: 77.18 (-0.29), GMED: 27.40 (+0.11), SYK: 101.80 (+0.19), AMDA: 0.56 (+0.01)
3 Stocks Under $10 Making Big Moves Higher
at The Street - Thu Jun 11, 12:55PM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
CLF: 2.99 (+0.02), AMDA: 0.56 (+0.01)
Europe Spine Surgery Devices Market 2015 - Analysis & Forecast to 2019
M2 - Tue Jun 09, 5:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/28wwzk/europe_spine) has announced the addition of the "Europe Spine Surgery Devices Market by Product (Spinal Fusion & Fixation Devices, Spine Biologics, Non-Fusion Implants, Spine Bone Stimulators), by End-User (Orthopedic Clinics & Spine Centers, Hospitals), by Geography - Analysis & Forecast to 2019" report to their offering. The European spine surgery devices market is expected to reach $2,993.6 million by 2019, at a CAGR of 7.3% from 2014 to 2019. This is mainly due to the increasing incidences of spinal deformities such as disc compression amongst the aging population in the European region, and the popularity of non-fusion devices such as artificial spinal disc and nucleus. The increasing demand from the aging population, along with the advancement in medical technology (minimally invasive techniques and biologics) is driving the demand for the spine surgery devices market. In this report, the spine surgery devices market is broadly segmented into four classes such as fusion, non-fusion, spinal decompression and spine biologics. Fusion category can be divided into spine fusion and fixation and spinal bone stimulators. Non-fusion segment consists of motion preservation technologies such as dynamic stabilization, artificial discs, annual repair and nucleus replacement. Vertebral compression factures treatment category includes market for vertebroplasty and kyphoplasty kits. Spinal decompression segment consists of niche markets such as corpectomy, disectomy, foraminotomy / forminectomy and laminotomy / laminectomy. Allogarfts, bone morphonenetic proteins, demineralised bone matrix, bone substitutes and machined bones, together contribute to overall category of spine biologics. The Europe Spine Surgery Devices market is a competitive market with a number of market players. As of 2014, the Europe Spine Surgery Devices market is estimated to be dominated by Stryker Corporation (U.S.), DePuy Synthes Companies of Johnson & Johnson (U.S.), Zimmer Holdings, Inc. (U.S.), Smith & Nephew Plc (U.K.), Tornier, Inc. (France) and Biomet, Inc. (U.S.). New product launches, mergers & acquisition, agreements, approvals are the major strategies adopted by most market players to achieve growth in the Europe spine surgery devices market. Companies Mentioned - Alphatec Spine, Inc. - Amedica Corporation - Biomet, Inc. - Depuy Synthes Companies. - Globus Medical, Inc. - Integra Lifesciences Holdings Corporation. - Medtronic, Inc. (U.S.) - Nuvasive Inc - Stryker Corporation - Zimmer Holding, Inc. For more information visit http://www.researchandmarkets.com/research/28...rope_spine
ZMH: 113.56 (+0.29), SNN: 35.39 (+0.21), JNJ: 99.88 (+0.86), MDT: 77.18 (-0.29), GMED: 27.40 (+0.11), SYK: 101.80 (+0.19), AMDA: 0.56 (+0.01)
North America Spine Surgery Devices Market by Product, by End User, by Geography - Analysis and Forecast to 2019
M2 - Thu May 28, 3:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/h2jfwx/north_america) has announced the addition of the "North America Spine Surgery Devices Market by Product, by End User, by Geography - Analysis and Forecast to 2019" report to their offering. The North American spine surgery devices market is expected to register a CAGR of 7.5%, with the U.S. having the maximum market share. The market, by product type, encompasses spinal fusion and fixation devices, spine biologics devices, VCF treatment devices, non-fusion implant devices, and spine bone stimulators devices. Of these, the spinal fusion and fixation devices segment is the largest and fastest-growing segment. Key players focus on securing FDA approvals to launch their products in the market. For instance Alphatec Spine, Inc. announced that its new product, the AlphaTec Solus, had received regulatory approval from the FDA. The addition of this new product expanded the company's portfolio of total bone constructs. The report shares a competitive view of various companies in the market, in terms of the geographies they operate in, revenue bifurcation, and their market shares. The report provides brief insights about the current scenario in the market and its future prospects. Key players in this market include Alphatec Spine, Inc. (U.S.), Biomet, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Integra LifeSciences (U.S.). Key Topics Covered - Introduction - Research Methodology - Executive Summary - Market Overview - North America Spine Surgery Devices Market, By Product - North America Spine Surgery Devices Market, By End User - North America Spine Surgery Devices Market, By Country - North America Spine Surgery Devices Market: Competitive Landscape - Spine Surgery Market, By Company - Appendix Companies Mentioned - Alphatec Spine - Amedica Corporation - Biomet - Depuy Synthes Companies - Globus Medical - Integra Lifesciences Holdings Corporation. - Medtronic - Nuvasive - Stryker Corporation - Zimmer Holding For more information visit http://www.researchandmarkets.com/research/h2...th_america
MDT: 77.18 (-0.29), GMED: 27.40 (+0.11), SYK: 101.80 (+0.19), AMDA: 0.56 (+0.01)
5 Stocks Under $10 Set to Soar
at The Street - Thu May 21, 11:40AM CDT
These under-$10 stocks look ready to break out and trade higher from current levels.
SGYP: 8.21 (-0.03), PTX: 5.04 (-0.13), AKAO: 7.25 (unch), CRCM: 5.95 (-0.04), AMDA: 0.56 (+0.01)
Amedica Announces Participation in 2015 LD MICRO Invitational Conference
GlobeNewswire - Wed May 20, 3:05PM CDT
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced its expected participation in the following investor conference:
AMDA: 0.56 (+0.01)
Ditch These 3 Terrible IPOs
Greg Guenthner - Daily Reckoning - Tue May 12, 8:54AM CDT
This post Ditch These 3 Terrible IPOs appeared first on Daily Reckoning . Chasing initial public offerings becomes a spectator sport in a strong bull market and every financial journalist in the biz covers the first few days of a new stock's...
ETSY: 18.85 (+0.20), TCS: 18.36 (+0.36), AMDA: 0.56 (+0.01)
Amedica's (AMDA) CEO Sonny Bal on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sat May 09, 1:58PM CDT
AMDA: 0.56 (+0.01)
Amedica beats by $0.04, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu May 07, 4:40PM CDT
AMDA: 0.56 (+0.01)
Amedica Corporation Reports First Quarter 2015 Financial Results
GlobeNewswire - Thu May 07, 3:28PM CDT
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced financial results for the first quarter ended March 31, 2015.
AMDA: 0.56 (+0.01)
Amedica Corporation Has Significant Upside Potential
Micro-Cap Gem Finder - at Seeking Alpha - Tue May 05, 11:46AM CDT
AMDA: 0.56 (+0.01)
Health Care Equipment Equities Technical Study -- Boston Scientific, Abbott Laboratories, Accuray, Zimmer Holdings, and Amedica
PR Newswire - Tue May 05, 7:30AM CDT
Editor Note: For more information about this release, please scroll to bottom.
ZMH: 113.56 (+0.29), BSX: 17.41 (-0.10), ABT: 51.03 (+0.09), ARAY: 6.64 (+0.04), AMDA: 0.56 (+0.01)
Amedica Corporation to Release First Quarter 2015 Financial Results and Host Conference Call
GlobeNewswire - Thu Apr 23, 3:05PM CDT
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today that it will release financial results for its first quarter 2015 on Thursday, May 7, 2015, after the market closes.
AMDA: 0.56 (+0.01)
Amedica Announces Preliminary Q2 2015 Financial Results and Update on Recent FDA Response
GlobeNewswire - Mon Jul 27, 3:15PM CDT
Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopedic implants, today announced that it expects to report second quarter 2015 revenue in the range of $4.7 million and $4.9 million, as compared to $4.7 million during the first quarter of 2015.
AMDA: 0.56 (+0.01)
Amedica to enter into OEM supply agreement for silicon nitride spinal implants
M2 - Fri Jul 24, 6:07AM CDT
Biomaterial company Amedica Corporation (NasdaqCM:AMDA) reported on Thursday that it has signed an original equipment manufacturer (OEM) letter of intent supply agreement with a leading orthopedic device design and manufacturing company (customer) to provide superior and innovative solutions to the market.
AMDA: 0.56 (+0.01)
Amedica Corporation Signs Additional OEM Letter of Intent Supply Agreement
GlobeNewswire - Thu Jul 23, 3:15PM CDT
Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopedic implants, is pleased to announce that it has signed an original equipment manufacturer (OEM) letter of intent supply agreement with a leading orthopedic device design and manufacturing company.
AMDA: 0.56 (+0.01)
Early Briefing on Medical Appliances and Equipment Stocks - Amedica, Hologic, St. Jude Medical, AcelRx Pharma, and NuVasive
PR Newswire - Wed Jul 22, 8:00AM CDT
Equity Research Institute has initiated coverage on the following equities: Amedica Corporation (NASDAQ: AMDA), Hologic Inc. (NASDAQ: HOLX), St. Jude Medical Inc. (NYSE: STJ), AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX), and NuVasive Inc. (NASDAQ: NUVA). Free research report on Amedica can be accessed at https://www.EquityResearchInstitute.com/reports?keyword=AMDA On Tuesday, July 21, 2015, the NASDAQ Composite ended at 5,208.12, down 0.21%, the Dow Jones Industrial Average declined 1.00%, to finish the day at 17,919.29, and the S&P 500 closed at 2,119.21, down 0.43%. The losses were broad based as seven out of nine sectors ended the session in negative. Register for your complimentary reports at the links given below.
ACRX: 4.02 (+0.02), STJ: 74.06 (-0.13), NUVA: 54.52 (+4.05), HOLX: 37.71 (+0.17), AMDA: 0.56 (+0.01)
Amedica Corporation Provides Update on FDA Questions and Femoral Head Testing Protocol Feedback
GlobeNewswire - Tue Jul 07, 3:45PM CDT
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced that responses to the U.S. Food and Drug Administration ("FDA"
inquiries regarding the Company's cervical composite silicon nitride interbody device were submitted to the FDA on June 30, 2015. Additionally, the Company has received feedback from the FDA regarding its wear testing femoral head protocols. AMDA: 0.56 (+0.01)
Spinal Fusion - Pipeline Review, 2015
M2 - Fri Jun 26, 3:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/26cwc3/spinal_fusion) has announced the addition of the "Spinal Fusion - Pipeline Review, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key spinal fusion pipeline products. Scope - Extensive coverage of the Spinal Fusion products under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Spinal Fusion and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Products under Development 4 Spinal Fusion - Pipeline Products under Development by Companies 5 Spinal Fusion Companies and Product Overview 6 Spinal Fusion - Recent Developments 7 Appendix Companies Featured: - 4-Web Spine, LLC - Alphatec Holdings, Inc. - Amedica Corporation - APTO Orthopaedics - Aurora Spine Corporation - Bio2 Technologies, Inc. - Bonovo Orthopedics, Inc. - Cortical Concepts (Inactive) - DiFusion Technologies Inc. - ECA Medical Instruments, Inc. - Eden Spine, LLC - Eminent Spine, LLC - Exactech, Inc. - Expanding Orthopedics Inc. - Globus Medical, Inc. - H. Lee Moffitt Cancer Center & Research Institute, Inc. - Implants International Limited - Integra LifeSciences Holdings Corporation - Intelligent Implant Systems, LLC - Intrinsic Therapeutics, Inc. - Jemo Spine, LLC. - Kspine, Inc. - Medtronic plc - MicroPort Scientific Corporation - Nasseo, Inc. - NLT SPINE - NuVasive, Inc. - OsteoGeneX Inc. - OsteoVantage, Inc. - Paradigm Spine, LLC For more information visit http://www.researchandmarkets.com/research/26...nal_fusion
ATEC: 1.37 (+0.01), MDT: 77.18 (-0.29), IARTV: 65.00 (-37.45), GMED: 27.40 (+0.11), EXAC: 20.01 (-0.07), NUVA: 54.52 (+4.05), AMDA: 0.56 (+0.01)
Asia Pacific Spine Surgery Devices Market 2015-2019: Non-Fusion Implants, Spinal Fusion & Fixation Devices, Spine Biologics, Spine Bone Stimulators, Vertebral Compression Fracture Treatment Devices
M2 - Thu Jun 25, 9:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w34wfd/asia_pacific) has announced the addition of the "Asia Pacific Spine Surgery Devices Market by Products (Non-Fusion Implants, Spinal Fusion & Fixation Devices, Spine Biologics, Spine Bone Stimulators, Vertebral Compression Fracture Treatment Devices), by End-User, by Geography - Analysis & Forecast" report to their offering. The APAC Spine Surgery Devices Market is expected to reach $2,223.1 million by 2019, at a CAGR of 10.5% from 2014 to 2019 This is mainly due to the increasing incidents of spinal deformities, such as disc compression amongst the aging population in the Asia-Pacific region, and the popularity of non-fusion devices, such as artificial spinal disc and nucleus. The increasing demand from the aging population, along with the advancement in medical technology, is driving the demand for the spine surgery device market in this region. In this report, the spine surgery devices market is broadly segmented into four classes such as fusion, non-fusion, spinal decompression, and spine biologics. The fusion category can be divided into spine fusion and fixation and spinal bone stimulators. Non-fusion segment consists of motion preservation technologies, such as dynamic stabilization, artificial discs, annual repair and nucleus replacement. The vertebral compression factures treatment category includes market for vertebroplasty and kyphoplasty kits. Spinal decompression segment consists of niche markets, such as corpectomy, disectomy, foraminotomy/forminectomy, and laminotomy/laminectomy. Allogarfts, bone morphonenetic proteins, demineralised bone matrix, bone substitutes, and machined bones together contribute to the overall category of spine biologics. New product launches, mergers & acquisitions, agreements, and approvals are the major strategies adopted by most of these market players to achieve growth in the APAC spine surgery devices market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Spine Surgery Devices Market, By Product 6 Spine Surgery Devices Market, By End-Users 7 Spine Surgery Devices Market, By Geography 8 Apac Spine Surgery Devices Market: Competitive Landscape 9 Spine Surgery Devices Market, By Company - Alphatec Spine, Inc. - Amedica Corporation - Biomet, Inc. - Depuy Synthes Companies. - Globus Medical, Inc. - Integra Lifesciences Holdings Corporation. - Medtronic, Inc. (U.S.) - Nuvasive Inc - Stryker Corporation - Zimmer Holding, Inc. For more information visit http://www.researchandmarkets.com/research/w3...ia_pacific
MDT: 77.18 (-0.29), GMED: 27.40 (+0.11), SYK: 101.80 (+0.19), AMDA: 0.56 (+0.01)
3 Stocks Under $10 Making Big Moves Higher
at The Street - Thu Jun 11, 12:55PM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
CLF: 2.99 (+0.02), AMDA: 0.56 (+0.01)
Europe Spine Surgery Devices Market 2015 - Analysis & Forecast to 2019
M2 - Tue Jun 09, 5:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/28wwzk/europe_spine) has announced the addition of the "Europe Spine Surgery Devices Market by Product (Spinal Fusion & Fixation Devices, Spine Biologics, Non-Fusion Implants, Spine Bone Stimulators), by End-User (Orthopedic Clinics & Spine Centers, Hospitals), by Geography - Analysis & Forecast to 2019" report to their offering. The European spine surgery devices market is expected to reach $2,993.6 million by 2019, at a CAGR of 7.3% from 2014 to 2019. This is mainly due to the increasing incidences of spinal deformities such as disc compression amongst the aging population in the European region, and the popularity of non-fusion devices such as artificial spinal disc and nucleus. The increasing demand from the aging population, along with the advancement in medical technology (minimally invasive techniques and biologics) is driving the demand for the spine surgery devices market. In this report, the spine surgery devices market is broadly segmented into four classes such as fusion, non-fusion, spinal decompression and spine biologics. Fusion category can be divided into spine fusion and fixation and spinal bone stimulators. Non-fusion segment consists of motion preservation technologies such as dynamic stabilization, artificial discs, annual repair and nucleus replacement. Vertebral compression factures treatment category includes market for vertebroplasty and kyphoplasty kits. Spinal decompression segment consists of niche markets such as corpectomy, disectomy, foraminotomy / forminectomy and laminotomy / laminectomy. Allogarfts, bone morphonenetic proteins, demineralised bone matrix, bone substitutes and machined bones, together contribute to overall category of spine biologics. The Europe Spine Surgery Devices market is a competitive market with a number of market players. As of 2014, the Europe Spine Surgery Devices market is estimated to be dominated by Stryker Corporation (U.S.), DePuy Synthes Companies of Johnson & Johnson (U.S.), Zimmer Holdings, Inc. (U.S.), Smith & Nephew Plc (U.K.), Tornier, Inc. (France) and Biomet, Inc. (U.S.). New product launches, mergers & acquisition, agreements, approvals are the major strategies adopted by most market players to achieve growth in the Europe spine surgery devices market. Companies Mentioned - Alphatec Spine, Inc. - Amedica Corporation - Biomet, Inc. - Depuy Synthes Companies. - Globus Medical, Inc. - Integra Lifesciences Holdings Corporation. - Medtronic, Inc. (U.S.) - Nuvasive Inc - Stryker Corporation - Zimmer Holding, Inc. For more information visit http://www.researchandmarkets.com/research/28...rope_spine
ZMH: 113.56 (+0.29), SNN: 35.39 (+0.21), JNJ: 99.88 (+0.86), MDT: 77.18 (-0.29), GMED: 27.40 (+0.11), SYK: 101.80 (+0.19), AMDA: 0.56 (+0.01)
North America Spine Surgery Devices Market by Product, by End User, by Geography - Analysis and Forecast to 2019
M2 - Thu May 28, 3:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/h2jfwx/north_america) has announced the addition of the "North America Spine Surgery Devices Market by Product, by End User, by Geography - Analysis and Forecast to 2019" report to their offering. The North American spine surgery devices market is expected to register a CAGR of 7.5%, with the U.S. having the maximum market share. The market, by product type, encompasses spinal fusion and fixation devices, spine biologics devices, VCF treatment devices, non-fusion implant devices, and spine bone stimulators devices. Of these, the spinal fusion and fixation devices segment is the largest and fastest-growing segment. Key players focus on securing FDA approvals to launch their products in the market. For instance Alphatec Spine, Inc. announced that its new product, the AlphaTec Solus, had received regulatory approval from the FDA. The addition of this new product expanded the company's portfolio of total bone constructs. The report shares a competitive view of various companies in the market, in terms of the geographies they operate in, revenue bifurcation, and their market shares. The report provides brief insights about the current scenario in the market and its future prospects. Key players in this market include Alphatec Spine, Inc. (U.S.), Biomet, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Integra LifeSciences (U.S.). Key Topics Covered - Introduction - Research Methodology - Executive Summary - Market Overview - North America Spine Surgery Devices Market, By Product - North America Spine Surgery Devices Market, By End User - North America Spine Surgery Devices Market, By Country - North America Spine Surgery Devices Market: Competitive Landscape - Spine Surgery Market, By Company - Appendix Companies Mentioned - Alphatec Spine - Amedica Corporation - Biomet - Depuy Synthes Companies - Globus Medical - Integra Lifesciences Holdings Corporation. - Medtronic - Nuvasive - Stryker Corporation - Zimmer Holding For more information visit http://www.researchandmarkets.com/research/h2...th_america
MDT: 77.18 (-0.29), GMED: 27.40 (+0.11), SYK: 101.80 (+0.19), AMDA: 0.56 (+0.01)
5 Stocks Under $10 Set to Soar
at The Street - Thu May 21, 11:40AM CDT
These under-$10 stocks look ready to break out and trade higher from current levels.
SGYP: 8.21 (-0.03), PTX: 5.04 (-0.13), AKAO: 7.25 (unch), CRCM: 5.95 (-0.04), AMDA: 0.56 (+0.01)
Amedica Announces Participation in 2015 LD MICRO Invitational Conference
GlobeNewswire - Wed May 20, 3:05PM CDT
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced its expected participation in the following investor conference:
AMDA: 0.56 (+0.01)
Ditch These 3 Terrible IPOs
Greg Guenthner - Daily Reckoning - Tue May 12, 8:54AM CDT
This post Ditch These 3 Terrible IPOs appeared first on Daily Reckoning . Chasing initial public offerings becomes a spectator sport in a strong bull market and every financial journalist in the biz covers the first few days of a new stock's...
ETSY: 18.85 (+0.20), TCS: 18.36 (+0.36), AMDA: 0.56 (+0.01)
Amedica's (AMDA) CEO Sonny Bal on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sat May 09, 1:58PM CDT
AMDA: 0.56 (+0.01)
Amedica beats by $0.04, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu May 07, 4:40PM CDT
AMDA: 0.56 (+0.01)
Amedica Corporation Reports First Quarter 2015 Financial Results
GlobeNewswire - Thu May 07, 3:28PM CDT
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced financial results for the first quarter ended March 31, 2015.
AMDA: 0.56 (+0.01)
Amedica Corporation Has Significant Upside Potential
Micro-Cap Gem Finder - at Seeking Alpha - Tue May 05, 11:46AM CDT
AMDA: 0.56 (+0.01)
Health Care Equipment Equities Technical Study -- Boston Scientific, Abbott Laboratories, Accuray, Zimmer Holdings, and Amedica
PR Newswire - Tue May 05, 7:30AM CDT
Editor Note: For more information about this release, please scroll to bottom.
ZMH: 113.56 (+0.29), BSX: 17.41 (-0.10), ABT: 51.03 (+0.09), ARAY: 6.64 (+0.04), AMDA: 0.56 (+0.01)
Amedica Corporation to Release First Quarter 2015 Financial Results and Host Conference Call
GlobeNewswire - Thu Apr 23, 3:05PM CDT
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today that it will release financial results for its first quarter 2015 on Thursday, May 7, 2015, after the market closes.
AMDA: 0.56 (+0.01)
